Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Samsung Biologics (207940.KS)

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (Won) Price Target (Won) Rating
2021-08-13972679-No Rating
2022-08-089000001070000Buy
2023-01-288090001060000Buy
2023-04-12800000980000Buy
2024-01-11751000990000Buy
2024-03-128400001050000Buy
2024-09-279860001250000Buy

Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day.